Company Quick10K Filing
PHI
10-Q 2019-06-30 Filed 2019-08-09
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-18
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-04
10-K 2017-12-31 Filed 2018-02-23
10-Q 2017-09-30 Filed 2017-11-03
10-Q 2017-06-30 Filed 2017-08-04
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-02-27
10-Q 2016-09-30 Filed 2016-11-07
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-09
10-K 2015-12-31 Filed 2016-02-29
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-09
10-K 2013-12-31 Filed 2014-02-28
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-06-30 Filed 2013-08-02
10-Q 2013-03-31 Filed 2013-05-03
10-K 2012-12-31 Filed 2013-03-15
10-Q 2012-09-30 Filed 2012-11-05
10-Q 2012-06-30 Filed 2012-08-06
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-03-14
10-Q 2011-09-30 Filed 2011-11-07
10-Q 2011-06-30 Filed 2011-08-03
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-14
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-04
10-Q 2010-03-31 Filed 2010-05-05
10-K 2009-12-31 Filed 2010-03-08
8-K 2019-09-04
8-K 2019-08-20
8-K 2019-08-02
8-K 2019-07-22
8-K 2019-07-11
8-K 2019-06-18
8-K 2019-06-13
8-K 2019-06-05
8-K 2019-06-05
8-K 2019-05-20
8-K 2019-04-26
8-K 2019-04-01
8-K 2019-03-15
8-K 2019-03-13
8-K 2019-02-19
8-K 2018-10-12
8-K 2018-10-08
8-K 2018-09-24
8-K 2018-09-20
8-K 2018-09-10
8-K 2018-08-27
8-K 2018-08-13
8-K 2018-07-27
8-K 2018-07-17
8-K 2018-07-02
8-K 2018-06-15
8-K 2018-06-15
8-K 2018-03-07

PHI Financials

PHII Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS) 41 77% -17.5 -11% 226 289 73 56 -25 -14 243
Clovis Oncology (CLVS) 219 0% -0.0 -56% 717 804 134 0 -400 -394 18
Cementos Pacasmayo Saa (CPAC) 4,145 0% 2,863 1,412 0 0 0 0 4,145
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ) 123 1.0 0% 962 869 0 0 3 15 14
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash335112341221923364462793342397616592430
Accounts Receivable129142141138156174174172180203181160173156145151148142138126148153186187194197182179183
Inventory575757606266666667707172737474717070697069697073767981777874575354
PP&E6736656606576727131,0387647577821,0968348238761,1939179118871,2399088939171,2888979189101,3779369349241,380896886
Assets9679819649681,0631,1171,1481,1571,2041,2391,1731,2931,2971,4011,3951,4201,4391,4561,4301,4641,4471,4591,4481,4201,4291,3941,4021,3841,3881,3641,2621,4501,453
Accounts Payable192118264030262641283753343128566329316223212922283137375139503971
Long-Term Debt316335346330358369387379376388379507500582543540536578558588595632634636633600618622622630630700700
Liabilities4965074874895776206486496766976137377278127988138248318038458228388498348458127897867967877899801,018
Stockholders' Equity471474477480486497500508528542560555570588597607615624627620625621600586584582613598592577473492462
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue136146139138161171177179196430281197212379211204199215187164167158145135146150148160169169176152165
Cost of Revenue
Gross Profit
R&D
SG&A889910101181024119121119111212121212138131411151514162518
Tax02-0145-06131011281123767-24555120000011
Net Income14326639201417313177109112578-17316-329-17-7-12-106-35-31
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating16818712531281037621306330393926-317-8711196-17-17-339
Cash Investing-34-17-6-35-12-39021-70-29094-200-45-27-35-80-8-9-22-35-889286-4-9-65-4
Cash Financing1911-162811160-313-9968882-39221843-213073721126-331840640